Ahrens Brenton Karl Insider Trades

Insider Trading History

Track insider trading activity for Ahrens Brenton Karl. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $874 29,125 shares
Last Trade
Dec 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.6k 29,125 shares
$0.81
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $3.4k 113,276 shares
Last Trade
Jun 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$339k 113,276 shares
$2.99
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $19.4k 647,059 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.01M 647,059 shares
$3.10
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $1.42k 47,436 shares
Last Trade
Mar 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$319k 47,436 shares
$6.72
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $1.94k 64,706 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.95M 64,706 shares
$30.15
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $590 19,671 shares
Last Trade
Jun 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.99M 19,671 shares
$101.12
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $185 6,154 shares
Last Trade
May 24, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$578k 6,154 shares
$93.90
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $0 0 shares
Last Trade
May 24, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$578k 6,154 shares
$93.90
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $52k 1,733,170 shares
Last Trade
May 30, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$92.3M 506,656 shares
$182.25
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $185 6,154 shares
Last Trade
May 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.03
Dexcom
Dexcom DXCM
Director
Holding Value $726k 10,000 shares
Last Trade
Apr 13, 2006 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$72.59
Dexcom
Dexcom DXCM
10% owner
Holding Value $126M 1,733,941 shares
Last Trade
Apr 19, 2005 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$72.59
Dexcom
Dexcom DXCM
10% owner
Holding Value $0 0 shares
Last Trade
Apr 19, 2005 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$72.59
Dexcom
Dexcom DXCM
10% owner
Holding Value $1.81M 25,000 shares
Last Trade
Apr 13, 2005 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$72.59
Dexcom
Dexcom DXCM
Director
Holding Value $0 0 shares
Last Trade
Apr 13, 2005 Sale
No data
No data
$72.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up